Assignee
SILLAJEN INC
KR·2 granted patents·11 pending applications·1 citations·filing 2016–2024
Top patents by PatentIndex Score
13 records- 0167US10646524B2Modified oncolytic vaccinia viruses expressing a cytokine and a car-boxylesterase and methods of use thereofSILLAJEN INC·Filed 2016·Granted May 12, 2020·1 cites·21 claims
- 0262US2024325473A1Cancer TreatmentsSILLAJEN INC·Filed 2024·Application pending·0 cites
- 0357US2024252563A1Cancer treatmentsSILLAJEN INC·Filed 2023·Application pending·0 cites
- 0455US2025057844A1Methods of treating neoplastic diseasesSILLAJEN INC·Filed 2022·Application pending·0 cites
- 0553US2025049926A1Pharmaceutical compositions comprising modified betacyclodextrinsSILLAJEN INC·Filed 2022·Application pending·0 cites
- 0652US2026091070A1Novel use of oncolytic virusSILLAJEN INC·Filed 2023·Application pending·0 cites
- 0751US2025049801A1Pharmaceutical combinations for use in the treatment of neoplastic diseasesSILLAJEN INC·Filed 2022·Application pending·0 cites
- 0850US2026000722A1Oncolytic virus simultaneously expressing cd55 and cd59SILLAJEN INC·Filed 2022·Application pending·0 cites
- 0949US2025161310A1Pharmaceutical combinations for use in the treatment of neoplastic diseasesSILLAJEN INC·Filed 2023·Application pending·0 cites
- 1046US2024067936A1Oncolytic virus and uses thereofSILLAJEN INC·Filed 2022·Application pending·0 cites
- 1142US10517910B2Compositions and methods for viral embolizationSILLAJEN INC·Filed 2016·Granted Dec 31, 2019·0 cites·17 claims
- 1235US2022381769A1Immune Assay for Monitoring Response to Oncolytic Vaccinia Virus and Uses ThereofSILLAJEN INC·Filed 2020·Application pending·0 cites
- 1332US2020085891A1Oncolytic vaccinia virus and checkpoint inhibitor combination therapySILLAJEN INC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →